A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways

MLA

Claude Auriault, et al. “A Novel Dominant-Negative Mutant Form of Epstein-Barr Virus Latent Membrane Protein-1 (LMP1) Selectively and Differentially Impairs LMP1 and TNF Signaling Pathways.” Oncogene, vol. 23, no. 15, Feb. 2004. EBSCOhost, https://doi.org/10.1038/sj.onc.1207432⟩.

APA

Claude Auriault, Véronique Fafeur, Jean Coll, Alexandra Mougel, Eric Adriaenssens, Estelle Loing, & Gautier Goormachtigh. (2004). A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways. Oncogene, 23(15). https://doi.org/10.1038/sj.onc.1207432⟩

Chicago

Claude Auriault, Véronique Fafeur, Jean Coll, Alexandra Mougel, Eric Adriaenssens, Estelle Loing, and Gautier Goormachtigh. 2004. “A Novel Dominant-Negative Mutant Form of Epstein-Barr Virus Latent Membrane Protein-1 (LMP1) Selectively and Differentially Impairs LMP1 and TNF Signaling Pathways.” Oncogene 23 (15). doi:10.1038/sj.onc.1207432⟩.